DOYLESTOWN, PA -- (MARKET WIRE) -- September 19, 2006 -- QuantRx® Biomedical Corporation (OTCBB: QTXB), a bio-medical company that seeks to develop, acquire, and commercialize proprietary medical technology and products for diagnostics and therapeutic purposes, today announced the appointment of Dr. Arthur Hull Hayes, Jr. to the Company's Board of Directors.
